Compounds > sorafenib
Page last updated: 2024-09-05

sorafenib and 1-methylpropyl-2-imidazolyl disulfide

sorafenib has been researched along with 1-methylpropyl-2-imidazolyl disulfide in 1 studies

Compound Research Comparison

Studies
(sorafenib)		Trials
(sorafenib)		Recent Studies (post-2010)
(sorafenib)		Studies
(1-methylpropyl-2-imidazolyl disulfide)		Trials
(1-methylpropyl-2-imidazolyl disulfide)		Recent Studies (post-2010) (1-methylpropyl-2-imidazolyl disulfide)
6,5207305,25161546

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)1-methylpropyl-2-imidazolyl disulfide (IC50)
Replicase polyprotein 1abBetacoronavirus England 17.6
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 20.14
ThioredoxinHomo sapiens (human)2.11

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cao, LP; Weng, XY; Wu, J; Xie, HY; Zhang, C; Zheng, SS1

Other Studies

1 other study(ies) available for sorafenib and 1-methylpropyl-2-imidazolyl disulfide

ArticleYear
Synergistic interaction between thioredoxin inhibitor 1-methylpropyl 2-imidazolyl disulfide and sorafenib in liver cancer cells.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2020, Volume: 19, Issue:3

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Disulfides; Drug Synergism; Humans; Imidazoles; Inhibitory Concentration 50; Liver Neoplasms; Sorafenib; Thioredoxins

2020